# Safety, Tolerability and Pharmacokinetics of Genz-682452 in Healthy Men

> **NCT01674036** · PHASE1 · COMPLETED · sponsor: **Genzyme, a Sanofi Company** · enrollment: 63 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Genz-682452
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01674036
- **Lead sponsor:** Genzyme, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2014-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01674036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01674036, "Safety, Tolerability and Pharmacokinetics of Genz-682452 in Healthy Men". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01674036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*